Key statistics
On Friday, Neuronetics Inc (NRC:DUS) closed at 1.17, 9.35% above its 52-week low of 1.07, set on Nov 25, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.17 |
|---|---|
| High | 1.17 |
| Low | 1.17 |
| Bid | 1.30 |
| Offer | 1.33 |
| Previous close | 1.28 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 68.49m |
| Free float | 57.81m |
| P/E (TTM) | -- |
| Market cap | 97.25m USD |
| EPS (TTM) | -0.8344 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 07:12 GMT.
More ▼
Announcements
- TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
- Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
- New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
- NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
- Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
- Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
- Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
More ▼
